Aemetis, Inc. (NASDAQ:AMTX) Receives $12.95 Average Target Price from Analysts

Aemetis, Inc. (NASDAQ:AMTX) has been given an average rating of “Moderate Buy” by the five analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $12.95.

AMTX has been the topic of a number of research analyst reports. UBS Group decreased their price target on Aemetis from $8.25 to $7.75 and set a “buy” rating on the stock in a research note on Monday, August 19th. Truist Financial restated a “hold” rating and issued a $3.50 price objective (down from $4.00) on shares of Aemetis in a report on Wednesday, July 31st. StockNews.com upgraded Aemetis to a “sell” rating in a report on Wednesday, July 31st. Ascendiant Capital Markets cut their price objective on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a report on Tuesday, September 3rd. Finally, HC Wainwright restated a “buy” rating and issued a $28.00 price objective on shares of Aemetis in a report on Friday, August 2nd.

Institutional Trading of Aemetis

A number of institutional investors and hedge funds have recently modified their holdings of the business. Bank of New York Mellon Corp bought a new position in shares of Aemetis in the 2nd quarter worth about $306,000. Susquehanna Fundamental Investments LLC lifted its position in shares of Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock worth $379,000 after buying an additional 93,536 shares during the last quarter. Rhumbline Advisers lifted its position in shares of Aemetis by 2,837.1% in the 2nd quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after buying an additional 50,528 shares during the last quarter. Hutchinson Capital Management CA bought a new position in shares of Aemetis in the 2nd quarter worth about $70,000. Finally, State Board of Administration of Florida Retirement System bought a new position in shares of Aemetis in the 1st quarter worth about $84,000. 27.02% of the stock is owned by institutional investors and hedge funds.

Aemetis Stock Down 5.2 %

Shares of AMTX stock opened at $2.73 on Wednesday. Aemetis has a fifty-two week low of $2.10 and a fifty-two week high of $7.03. The stock has a market cap of $121.21 million, a P/E ratio of -2.33 and a beta of 1.24. The business has a fifty day simple moving average of $2.57 and a 200-day simple moving average of $3.10.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings results on Thursday, August 1st. The specialty chemicals company reported ($0.66) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.41) by ($0.25). The firm had revenue of $66.56 million during the quarter, compared to analyst estimates of $75.37 million. During the same period in the prior year, the company posted ($0.68) EPS. On average, sell-side analysts anticipate that Aemetis will post -2.07 earnings per share for the current year.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.